2023 annual financial data
Indivior Pharmaceuticals 2023 Operating margin
Direct answer
Operating margin was -14.27%.
Operating income was -156,000,000 USD and net income was -129,000,000 USD.
Operating cash flow was -300,000,000 USD.
Get free Indivior Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,093,000,000 USD
- Operating income
- -156,000,000 USD
- Net income
- -129,000,000 USD
- Operating cash flow
- -300,000,000 USD